BST.MC - Biotechnology Assets, S.A.

MCE - MCE Delayed Price. Currency in EUR
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/7/2023
Current
Market Cap (intraday)
22.55M
Enterprise Value
25.49M
Trailing P/E
1.32
Forward P/E
7.42
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
8.63
Price/Book (mrq)
5.60
Enterprise Value/Revenue
9.75
Enterprise Value/EBITDA
0.12

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) 1.55
52-Week Change 338.67%
S&P500 52-Week Change 34.08%
52 Week High 30.6900
52 Week Low 30.0900
50-Day Moving Average 30.4102
200-Day Moving Average 30.2865

Share Statistics

Avg Vol (3 month) 31.43M
Avg Vol (10 day) 3886.09k
Shares Outstanding 554.2M
Implied Shares Outstanding 6N/A
Float 828.73M
% Held by Insiders 149.25%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 06, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Dec 31, 2022

Profitability

Profit Margin -65.70%
Operating Margin (ttm)-58.71%

Management Effectiveness

Return on Assets (ttm)-5.66%
Return on Equity (ttm)-47.33%

Income Statement

Revenue (ttm)2.96M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-19.40%
Gross Profit (ttm)2.63M
EBITDA -711.12k
Net Income Avi to Common (ttm)-1.94M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)800.4k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)8.25M
Total Debt/Equity (mrq)212.89
Current Ratio (mrq)0.88
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-17.33k
Levered Free Cash Flow (ttm)-973.92k